Psychology and Neuroscience Faculty Database
Psychology and Neuroscience
Arts & Sciences
Duke University

 HOME > Arts & Sciences > pn > Faculty    Search Help Login pdf version printable version 

Publications of Scott H. Kollins    :chronological  alphabetical  combined  bibtex listing:

search PubMed.

Journal Articles

  1. Addicott, MA; Schechter, JC; Sapyta, JJ; Selig, JP; Kollins, SH; Weiss, MD (2019). Methylphenidate increases willingness to perform effort in adults with ADHD.. Pharmacol Biochem Behav, 183, 14-21. [doi]  [abs]
  2. Raman, S; Engelhard, M; Kollins, SH (2019). Driving the Point Home: Novel Approaches to Mitigate Crash Risk for Patients With ADHD.. Pediatrics. [doi]
  3. Mitchell, JT; Howard, AL; Belendiuk, KA; Kennedy, TM; Stehli, A; Swanson, JM; Hechtman, L; Arnold, LE; Hoza, B; Vitiello, B; Lu, B; Kollins, SH; Molina, BSG (2019). Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD.. Nicotine Tob Res, 21(5), 638-647. [doi]  [abs]
  4. Barry, CM; Sabhlok, A; Saba, VC; Majors, AD; Schechter, JC; Levine, EL; Streicher, M; Bennett, GG; Kollins, SH; Fuemmeler, BF (2019). An Automated Text-Messaging Platform for Enhanced Retention and Data Collection in a Longitudinal Birth Cohort: Cohort Management Platform Analysis.. Jmir Public Health and Surveillance, 5(2), e11666. [doi]  [abs]
  5. Lunsford-Avery, JR; Kollins, SH; Mittal, VA (2019). Eveningness diurnal preference associated with poorer socioemotional cognition and social functioning among healthy adolescents and young adults.. Chronobiol Int, 36(3), 439-444. [doi]  [abs]
  6. Fuemmeler, BF; Zucker, N; Sheng, Y; Sanchez, CE; Maguire, R; Murphy, SK; Kollins, SH; Hoyo, C (2019). Pre-Pregnancy Weight and Symptoms of Attention Deficit Hyperactivity Disorder and Executive Functioning Behaviors in Preschool Children.. International Journal of Environmental Research and Public Health, 16(4). [doi]  [abs]
  7. Do, EK; Zucker, NL; Huang, ZY; Schechter, JC; Kollins, SH; Maguire, RL; Murphy, SK; Hoyo, C; Fuemmeler, BF (2019). Associations between imprinted gene differentially methylated regions, appetitive traits and body mass index in children.. Pediatr Obes, 14(2), e12454. [doi]  [abs]
  8. Schechter, J; Do, EK; Zhang, JJ; Hoyo, C; Murphy, SK; Kollins, SH; Fuemmeler, B (2018). Effect of Prenatal Smoke Exposure on Birth Weight: The Moderating Role of Maternal Depressive Symptoms.. Nicotine Tob Res. [doi]  [abs]
  9. Lunsford-Avery, JR; Kollins, SH (2018). Editorial Perspective: Delayed circadian rhythm phase: a cause of late-onset attention-deficit/hyperactivity disorder among adolescents?. The Journal of Child Psychology and Psychiatry and Allied Disciplines, 59(12), 1248-1251. [doi]  [abs]
  10. Kollins, SH (2018). Moving Beyond Symptom Remission to Optimize Long-term Treatment of Attention-Deficit/Hyperactivity Disorder.. Jama Pediatr, 172(10), 901-902. [doi]
  11. Lunsford-Avery, JR; Engelhard, MM; Navar, AM; Kollins, SH (2018). Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk.. Scientific Reports, 8(1), 14158. [doi]  [abs]
  12. Faraone, SV; Childress, A; Wigal, SB; Kollins, SH; McDonnell, MA; DeSousa, NJ; Sallee, FR (2018). Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised.. J Atten Disord, 22(11), 1066-1073. [doi]  [abs]
  13. Gao, L; Liu, X; Millstein, J; Siegmund, KD; Dubeau, L; Maguire, RL; Jim Zhang, J; Fuemmeler, BF; Kollins, SH; Hoyo, C; Murphy, SK; Breton, CV (2018). Self-reported prenatal tobacco smoke exposure, AXL gene-body methylation, and childhood asthma phenotypes.. Clin Epigenetics, 10(1), 98. [doi]  [abs]
  14. Mitchell, JT; Weisner, TS; Jensen, PS; Murray, DW; Molina, BSG; Arnold, LE; Hechtman, L; Swanson, JM; Hinshaw, SP; Victor, EC; Kollins, SH; Wells, KC; Belendiuk, KA; Blonde, A; Nguyen, C; Ambriz, L; Nguyen, JL (2018). How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning.. J Atten Disord, 22(9_suppl), 49S-60S. [doi]  [abs]
  15. Lunsford-Avery, JR; Kollins, SH; Mitchell, JT (2018). Sluggish Cognitive Tempo in Adults Referred for an ADHD Evaluation: A Psychometric Analysis of Self- and Collateral Report.. J Atten Disord, 1087054718787894. [doi]  [abs]
  16. Dozmorov, MG; Bilbo, SD; Kollins, SH; Zucker, N; Do, EK; Schechter, JC; Zhang, JJ; Murphy, SK; Hoyo, C; Fuemmeler, BF (2018). Associations between maternal cytokine levels during gestation and measures of child cognitive abilities and executive functioning.. Brain Behav Immun, 70, 390-397. [doi]  [abs]
  17. Sanchez, CE; Barry, C; Sabhlok, A; Russell, K; Majors, A; Kollins, SH; Fuemmeler, BF (2018). Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis.. Obes Rev, 19(4), 464-484. [doi]  [abs]
  18. Lee, C-T; McClernon, FJ; Kollins, SH; Fuemmeler, BF (2018). Childhood ADHD Symptoms and Future Illicit Drug Use: The Role of Adolescent Cigarette Use.. Journal of Pediatric Psychology, 43(2), 162-171. [doi]  [abs]
  19. Sweitzer, MM; Kollins, SH; Kozink, RV; Hallyburton, M; English, J; Addicott, MA; Oliver, JA; McClernon, FJ (2018). ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.. Neuropsychopharmacology, 43(4), 851-858. [doi]  [abs]
  20. Schechter, JC; Fuemmeler, BF; Hoyo, C; Murphy, SK; Zhang, JJ; Kollins, SH (2018). Impact of Smoking Ban on Passive Smoke Exposure in Pregnant Non-Smokers in the Southeastern United States.. International Journal of Environmental Research and Public Health, 15(1). [doi]  [abs]
  21. Davis, NO; Bower, J; Kollins, SH (2018). Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD.. Plos One, 13(1), e0189749. [doi]  [abs]
  22. Murphy, SK; Itchon-Ramos, N; Visco, Z; Huang, Z; Grenier, C; Schrott, R; Acharya, K; Boudreau, M-H; Price, TM; Raburn, DJ; Corcoran, DL; Lucas, JE; Mitchell, JT; McClernon, FJ; Cauley, M; Hall, BJ; Levin, ED; Kollins, SH (2018). Cannabinoid exposure and altered DNA methylation in rat and human sperm.. Epigenetics : Official Journal of the Dna Methylation Society, 13(12), 1208-1221. [doi]  [abs]
  23. Mitchell, JT; McIntyre, EM; English, JS; Dennis, MF; Beckham, JC; Kollins, SH (2017). A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation.. J Atten Disord, 21(13), 1105-1120. [24305060], [doi]  [abs]
  24. McCullough, LE; Miller, EE; Calderwood, LE; Shivappa, N; Steck, SE; Forman, MR; A Mendez, M; Maguire, R; Fuemmeler, BF; Kollins, SH; D Bilbo, S; Huang, Z; Murtha, AP; Murphy, SK; Hébert, JR; Hoyo, C (2017). Maternal inflammatory diet and adverse pregnancy outcomes: Circulating cytokines and genomic imprinting as potential regulators?. Epigenetics : Official Journal of the Dna Methylation Society, 12(8), 688-697. [doi]  [abs]
  25. Schechter, JC; Kollins, SH (2017). Prenatal Smoke Exposure and ADHD: Advancing the Field.. Pediatrics, 139(2). [doi]
  26. Childress, AC; Kollins, SH; Cutler, AJ; Marraffino, A; Sikes, CR (2017). Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.. J Child Adolesc Psychopharmacol, 27(1), 66-74. [doi]  [abs]
  27. Lunsford-Avery, JR; Krystal, AD; Kollins, SH (2016). Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research.. Clin Psychol Rev, 50, 159-174. [doi]  [abs]
  28. Schoenfelder, EN; Kollins, SH (2016). Topical Review: ADHD and Health-Risk Behaviors: Toward Prevention and Health Promotion.. Journal of Pediatric Psychology, 41(7), 735-740. [doi]  [abs]
  29. Mitchell, JT; Sweitzer, MM; Tunno, AM; Kollins, SH; McClernon, FJ (2016). "I Use Weed for My ADHD": A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD.. Plos One, 11(5), e0156614. [doi]  [abs]
  30. Koblan, KS; Hopkins, SC; Sarma, K; Jin, F; Goldman, R; Kollins, SH; Loebel, A (2015). Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.. Neuropsychopharmacology, 40(12), 2745-2752. [doi]  [abs]
  31. Vitiello, B; Lazzaretto, D; Yershova, K; Abikoff, H; Paykina, N; McCracken, JT; McGough, JJ; Kollins, SH; Greenhill, LL; Wigal, S; Wigal, T; Riddle, MA (2015). Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up.. J Am Acad Child Adolesc Psychiatry, 54(7), 550-556. [doi]  [abs]
  32. Childress, AC; Brams, M; Cutler, AJ; Kollins, SH; Northcutt, J; Padilla, A; Turnbow, JM (2015). The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.. J Child Adolesc Psychopharmacol, 25(5), 402-414. [doi]  [abs]
  33. Mitchell, JT; Zylowska, L; Kollins, SH (2015). Mindfulness Meditation Training for Attention-Deficit/Hyperactivity Disorder in Adulthood: Current Empirical Support, Treatment Overview, and Future Directions.. Cognitive and Behavioral Practice, 22(2), 172-191. [doi]  [abs]
  34. Fuemmeler, BF; Hoyo, C; Murphy, S; Vidal, AC; Kollins, SH (2015). PRE-PREGNANCY OBESITY AND OFFSPRING NEUROBEHAVIORAL DEVELOPMENT. Annals of Behavioral Medicine, 49, S252-S252. [Gateway.cgi]
  35. Lee, C-T; Clark, TT; Kollins, SH; McClernon, FJ; Fuemmeler, BF (2015). Attention Deficit Hyperactivity Disorder symptoms and smoking trajectories: race and gender differences.. Drug Alcohol Depend, 148, 180-187. [doi]  [abs]
  36. Lee, CT; Clark, TT; Kollins, SH; McClernon, JF; Fuemmeler, BF (2015). Attention Deficit Hyperactivity Disorder symptoms and smoking trajectories: Race and gender differences. Drug and Alcohol Dependence, 148, 180-187. [doi]  [abs]
  37. Kollins, SH; Schoenfelder, EN; English, JS; Holdaway, A; Van Voorhees, E; O'Brien, BR; Dew, R; Chrisman, AK (2015). An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults. Journal of Substance Abuse Treatment, 48(1), 96-103. [doi]  [abs]
  38. Kollins, SH; Schoenfelder, EN; English, JS; Holdaway, A; Van Voorhees, E; O'Brien, BR; Dew, R; Chrisman, AK (2015). An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.. J Subst Abuse Treat, 48(1), 96-103. [doi]  [abs]
  39. Koblan, KS; Hopkins, SC; Sarma, K; Jin, F; Goldman, R; Kollins, SH; Loebel, A (2015). Dasotraline for the treatment of attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled, proof-of-concept trial in adults. Neuropsychopharmacology, 40(12), 2745-2752. [doi]  [abs]
  40. Wigal, SB; Greenhill, LL; Nordbrock, E; Connor, DF; Kollins, SH; Adjei, A; Childress, A; Stehli, A; Kupper, RJ (2014). A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.. J Child Adolesc Psychopharmacol, 24(10), 562-569. [doi]  [abs]
  41. Smith, TF; Anastopoulos, AD; Garrett, ME; Arias-Vasquez, A; Franke, B; Oades, RD; Sonuga-Barke, E; Asherson, P; Gill, M; Buitelaar, JK; Sergeant, JA; Kollins, SH; Faraone, SV; Ashley-Koch, A; IMAGE Consortium, (2014). Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity.. Am J Med Genet B Neuropsychiatr Genet, 165B(8), 691-704. [doi]  [abs]
  42. Adjei, A; Kupper, RJ; Teuscher, NS; Wigal, S; Sallee, F; Childress, A; Kollins, SH; Greenhill, L (2014). Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.. Clin Drug Investig, 34(11), 795-805. [doi]  [abs]
  43. Mitchell, JT; Dennis, MF; English, JS; Dennis, PA; Brightwood, A; Beckham, JC; Kollins, SH (2014). Ecological momentary assessment of antecedents and consequences of smoking in adults with attention-deficit/hyperactivity disorder.. Subst Use Misuse, 49(11), 1446-1456. [doi]  [abs]
  44. Kollins, SH; Adcock, RA (2014). ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: Implications for smoking and nicotine dependence. Progress in Neuro Psychopharmacology & Biological Psychiatry, 52, 70-78. [doi]  [abs]
  45. Kollins, SH; Adcock, RA (2014). ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.. Prog Neuropsychopharmacol Biol Psychiatry, 52, 70-78. [doi]  [abs]
  46. Schoenfelder, EN; Faraone, SV; Kollins, SH (2014). Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.. Pediatrics, 133(6), 1070-1080. [doi]  [abs]
  47. Kollins, SH; English, JS; Itchon-Ramos, N; Chrisman, AK; Dew, R; O'Brien, B; McClernon, FJ (2014). A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD.. J Atten Disord, 18(2), 158-168. [22508760], [doi]  [abs]
  48. Mitchell, JT; McIntyre, EM; McClernon, FJ; Kollins, SH (2014). Smoking motivation in adults with attention-deficit/hyperactivity disorder using the Wisconsin inventory of smoking dependence motives.. Nicotine Tob Res, 16(1), 120-125. [24078759], [doi]  [abs]
  49. Adjei, A; Kupper, RJ; Teuscher, NS; Wigal, S; Sallee, F; Childress, A; Kollins, SH; Greenhill, L (2014). Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers. Clinical Drug Investigation, 34(11), 795-805. [doi]  [abs]
  50. Mitchell, JT; Schick, RS; Hallyburton, M; Dennis, MF; Kollins, SH; Beckham, JC; McClernon, FJ (2014). Combined ecological momentary assessment and global positioning system tracking to assess smoking behavior: a proof of concept study.. J Dual Diagn, 10(1), 19-29. [doi]  [abs]
  51. Weisler, RH; Adler, LA; Kollins, SH; Goodman, DW; Hamdani, M; Dirks, B; Childress, AC (2014). Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate.. Neuropsychiatric Disease and Treatment, 10, 1-12. [24363557], [doi]  [abs]
  52. Lee, C-T; Fuemmeler, BF; McClernon, FJ; Ashley-Koch, A; Kollins, SH (2013). Nicotinic receptor gene variants interact with attention deficient hyperactive disorder symptoms to predict smoking trajectories from early adolescence to adulthood.. Addict Behav, 38(11), 2683-2689. [23899432], [doi]  [abs]
  53. Lee, C-T; McClernon, FJ; Kollins, SH; Prybol, K; Fuemmeler, BF (2013). Childhood economic strains in predicting substance use in emerging adulthood: mediation effects of youth self-control and parenting practices.. Journal of Pediatric Psychology, 38(10), 1130-1143. [23899658], [doi]  [abs]
  54. Kollins, SH; Schoenfelder, E; English, JS; McClernon, FJ; Dew, RE; Lane, SD (2013). Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).. Exp Clin Psychopharmacol, 21(5), 375-384. [24099358], [doi]  [abs]
  55. Fuemmeler, B; Lee, C-T; Ranby, KW; Clark, T; McClernon, FJ; Yang, C; Kollins, SH (2013). Individual- and community-level correlates of cigarette-smoking trajectories from age 13 to 32 in a U.S. population-based sample.. Drug Alcohol Depend, 132(1-2), 301-308. [23499056], [doi]  [abs]
  56. Kollins, SH; English, JS; Roley, ME; O'Brien, B; Blair, J; Lane, SD; McClernon, FJ (2013). Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.. Psychopharmacology (Berl), 227(1), 19-30. [23247366], [doi]  [abs]
  57. Riddle, MA; Yershova, K; Lazzaretto, D; Paykina, N; Yenokyan, G; Greenhill, L; Abikoff, H; Vitiello, B; Wigal, T; McCracken, JT; Kollins, SH; Murray, DW; Wigal, S; Kastelic, E; McGough, JJ; dosReis, S; Bauzó-Rosario, A; Stehli, A; Posner, K (2013). The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.. J Am Acad Child Adolesc Psychiatry, 52(3), 264-278.e2. [23452683], [doi]  [abs]
  58. Fuemmeler, B; Lee, CT; Ranby, KW; Clark, T; McClernon, FJ; Yang, C; Kollins, SH (2013). Individual- and community-level correlates of cigarette-smoking trajectories from age 13 to 32 in a U.S. population-based sample. Drug and Alcohol Dependence, 132(1-2), 301-308. [doi]  [abs]
  59. Wang, G-J; Volkow, ND; Wigal, T; Kollins, SH; Newcorn, JH; Telang, F; Logan, J; Jayne, M; Wong, CT; Han, H; Fowler, JS; Zhu, W; Swanson, JM (2013). Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.. Plos One, 8(5), e63023. [23696790], [doi]  [abs]
  60. Kollins, SH; English, JS; Roley, ME; O'Brien, B; Blair, J; Lane, SD; McClernon, FJ (2013). Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder. Psychopharmacology, 227(1), 19-30. [doi]  [abs]
  61. Mitchell, JT; Robertson, CD; Anastopolous, AD; Nelson-Gray, RO; Kollins, SH (2012). Emotion dysregulation and emotional impulsivity among adults with attention-deficit/hyperactivity disorder: Results of a preliminary study. Journal of Psychopathology and Behavioral Assessment, 34(4), 510-519. [doi]  [abs]
  62. Mitchell, JT; Van Voorhees, EE; Dennis, MF; McClernon, FJ; Calhoun, PS; Kollins, SH; Beckham, JC (2012). Assessing the role of attention-deficit/hyperactivity disorder symptoms in smokers with and without posttraumatic stress disorder.. Nicotine Tob Res, 14(8), 986-992. [22180583], [doi]  [abs]
  63. Davis, NO; Kollins, SH (2012). Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder.. Neurotherapeutics, 9(3), 518-530. [22678458], [doi]  [abs]
  64. Sallee, FR; Kollins, SH; Wigal, TL (2012). Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder.. J Child Adolesc Psychopharmacol, 22(3), 206-214. [22612526], [doi]  [abs]
  65. Van Voorhees, EE; Mitchell, JT; McClernon, FJ; Beckham, JC; Kollins, SH (2012). Sex, ADHD symptoms, and smoking outcomes: an integrative model.. Med Hypotheses, 78(5), 585-593. [22341778], [doi]  [abs]
  66. Fuemmeler, B; Lee, C-T; Ranby, KW; Stroo, M; Yang, C; Clark, K; Boynton, MH; Clark, T; McClernon, J; Kollins, S (2012). COMMUNITY AND INDIVIDUAL LEVEL SOCIAL CORRELATES OF SMOKING TRAJECTORIES FROM ADOLESCENCE TO ADULTHOOD. Annals of Behavioral Medicine, 43, S210-S210.
  67. Van Voorhees, E; McClernon, FJ; Fuemmeler, B; English, J; Holdaway, A; Hallyburton, M; Dew, R; Kollins, S (2012). An examination of differences in variables maintaining smoking behavior in adult smokers with and without attention-deficit/hyperactivity disorder. Addiction Research & Theory, 20(1), 72-81. [doi]  [abs]
  68. Bidwell, LC; Garrett, ME; McClernon, FJ; Fuemmeler, BF; Williams, RB; Ashley-Koch, AE; Kollins, SH (2012). A preliminary analysis of interactions between genotype, retrospective ADHD symptoms, and initial reactions to smoking in a sample of young adults.. Nicotine Tob Res, 14(2), 229-233. [21778150], [doi]  [abs]
  69. Faraone, SV; Spencer, TJ; Kollins, SH; Glatt, SJ; Goodman, D (2012). Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory study.. J Atten Disord, 16(2), 118-127. [21527575], [doi]  [abs]
  70. Volkow, ND; Wang, G-J; Tomasi, D; Kollins, SH; Wigal, TL; Newcorn, JH; Telang, FW; Fowler, JS; Logan, J; Wong, CT; Swanson, JM (2012). Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.. Journal of Neuroscience, 32(3), 841-849. [22262882], [doi]  [abs]
  71. Mitchell, JT; Robertson, CD; Anastopolous, AD; Nelson-Gray, RO; Kollins, SH (2012). Emotion dysregulation and emotional impulsivity among adults with attention-deficit/hyperactivity disorder: Results of a preliminary study. Journal of Psychopathology and Behavioral Assessment, 34(4), 510-519. [doi]  [abs]
  72. Ranby, KW; Boynton, MH; Kollins, SH; McClernon, FJ; Yang, C; Fuemmeler, BF (2012). Understanding the phenotypic structure of adult retrospective ADHD symptoms during childhood in the United States.. J Clin Child Adolesc Psychol, 41(3), 261-274. [22394329], [doi]  [abs]
  73. Volkow, ND; Wang, G-J; Newcorn, JH; Kollins, SH; Wigal, TL; Telang, F; Fowler, JS; Goldstein, RZ; Klein, N; Logan, J; Wong, C; Swanson, JM (2011). Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.. Mol Psychiatry, 16(11), 1147-1154. [20856250], [doi]  [abs]
  74. Anastopoulos, AD; Smith, TF; Garrett, ME; Morrissey-Kane, E; Schatz, NK; Sommer, JL; Kollins, SH; Ashley-Koch, A (2011). Self-Regulation of Emotion, Functional Impairment, and Comorbidity Among ChildrenWith AD/HD.. J Atten Disord, 15(7), 583-592. [20686097], [doi]  [abs]
  75. McClernon, FJ; Van Voorhees, EE; English, J; Hallyburton, M; Holdaway, A; Kollins, SH (2011). Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial.. Nicotine Tob Res, 13(9), 784-792. [21571687], [doi]  [abs]
  76. Bidwell, LC; McClernon, FJ; Kollins, SH (2011). Cognitive enhancers for the treatment of ADHD.. Pharmacol Biochem Behav, 99(2), 262-274. [21596055], [doi]  [abs]
  77. Kollins, SH; Jain, R; Brams, M; Segal, S; Findling, RL; Wigal, SB; Khayrallah, M (2011). Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.. Pediatrics, 127(6), e1406-e1413. [21555501], [doi]  [abs]
  78. Fuemmeler, BF; Østbye, T; Yang, C; McClernon, FJ; Kollins, SH (2011). Association between attention-deficit/hyperactivity disorder symptoms and obesity and hypertension in early adulthood: a population-based study.. Int J Obes (Lond), 35(6), 852-862. [20975727], [doi]  [abs]
  79. Kratochvil, CJ; Vaughan, BS; Stoner, JA; Daughton, JM; Lubberstedt, BD; Murray, DW; Chrisman, AK; Faircloth, MA; Itchon-Ramos, NB; Kollins, SH; Maayan, LA; Greenhill, LL; Kotler, LA; Fried, J; March, JS (2011). A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.. Pediatrics, 127(4), e862-e868. [21422081], [doi]  [abs]
  80. Kollins, SH; López, FA; Vince, BD; Turnbow, JM; Farrand, K; Lyne, A; Wigal, SB; Roth, T (2011). Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder.. J Child Adolesc Psychopharmacol, 21(2), 111-120. [21476931], [doi]  [abs]
  81. Van Voorhees, EE; Hardy, KK; Kollins, SH (2011). Reliability and validity of self- and other-ratings of symptoms of ADHD in adults.. J Atten Disord, 15(3), 224-234. [20424007], [doi]  [abs]
  82. Rizzi, TS; Arias-Vasquez, A; Rommelse, N; Kuntsi, J; Anney, R; Asherson, P; Buitelaar, J; Banaschewski, T; Ebstein, R; Ruano, D; Van der Sluis, S; Markunas, CA; Garrett, ME; Ashley-Koch, AE; Kollins, SH; Anastopoulos, AD; Hansell, NK; Wright, MJ; Montgomery, GW; Martin, NG; Harris, SE; Davies, G; Tenesa, A; Porteous, DJ; Starr, JM; Deary, IJ; St Pourcain, B; Davey Smith, G; Timpson, NJ; Evans, DM; Gill, M; Miranda, A; Mulas, F; Oades, RD; Roeyers, H; Rothenberger, A; Sergeant, J; Sonuga-Barke, E; Steinhausen, HC; Taylor, E; Faraone, SV; Franke, B; Posthuma, D (2011). The ATXN1 and TRIM31 genes are related to intelligence in an ADHD background: evidence from a large collaborative study totaling 4,963 subjects.. Am J Med Genet B Neuropsychiatr Genet, 156(2), 145-157. [21302343], [doi]  [abs]
  83. Jain, R; Segal, S; Kollins, SH; Khayrallah, M (2011). Corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry, 50(3), 313-313. [Gateway.cgi], [doi]
  84. Bidwell, LC; Dew, RE; Kollins, SH (2011). Erratum: alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.. Current Psychiatry Reports, 13(1), 76. [21136308], [doi]
  85. Kollins, SH; Youcha, S; Lasser, R; Thase, ME (2011). Lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder in adults with a history of depression or history of substance use disorder.. Innov Clin Neurosci, 8(2), 28-32. [21468295]  [abs]
  86. Jain, R; Segal, S; Kollins, SH; Khayrallah, M (2011). Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.. J Am Acad Child Adolesc Psychiatry, 50(2), 171-179. [21241954], [doi]  [abs]
  87. TS Rizzi, A Arias-Vasquez, N Rommelse, J Kuntsi, R Anney, P Asherson, J Buitelaar, T Banaschewski, R Ebstein, D Ruano, S Van der Sluis, CA Markunas, ME Garrett, AE Ashley-Koch, SH Kollins, AD Anastopoulos, NK Hansell, MJ Wright, GW Montgomery, NG Martin, SE Harris, G Davies, A Tenesa, DJ Porteous, JM Starr, IJ Deary, B St Pourcain, GD Smith, NJ Timpson, DM Evans, M Gill, A Miranda, F Mulas, RD Oades, H Roeyers, A Rothenberger, J Sergeant, E Sonuga-Barke, HC Steinhausen, E Taylor, SV Faraone, B Franke, D Posthuma (2010). The ATXN1 and TRIM31 Genes Are Related to Intelligence in an ADHD Background: Evidence From a Large Collaborative Study Totaling 4,963 Subjects.. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. [doi]  [abs]
  88. Wigal, SB; Kollins, SH; Childress, AC; Adeyi, B (2010). Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day.. Child and Adolescent Psychiatry and Mental Health, 4, 32. [21156071], [doi]  [abs]
  89. Dew, RE; Kollins, SH (2010). Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD.. Expert Opin Pharmacother, 11(17), 2907-2913. [20979573], [doi]  [abs]
  90. Kozink, RV; Kollins, SH; McClernon, FJ (2010). Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control.. Neuropsychopharmacology, 35(13), 2600-2606. [20861830], [doi]  [abs]
  91. Cinnamon Bidwell, L; Dew, RE; Kollins, SH (2010). Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.. Current Psychiatry Reports, 12(5), 366-373. [20652773], [doi]  [abs]
  92. Connor, DF; Findling, RL; Kollins, SH; Sallee, F; López, FA; Lyne, A; Tremblay, G (2010). Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.. Cns Drugs, 24(9), 755-768. [20806988], [doi]  [abs]
  93. AD Anastopoulos, TF Smith, ME Garrett, E Morrissey-Kane, NK Schatz, JL Sommer, SH Kollins, A Ashley-Koch (2010). Self-Regulation of Emotion, Functional Impairment, and Comorbidity Among Children With ADHD.. Journal of attention disorders. [doi]  [abs]
  94. Kollins, SH; McClernon, FJ; Van Voorhees, EE (2010). Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD).. Exp Clin Psychopharmacol, 18(3), 221-228. [20545386], [doi]  [abs]
  95. Kollins, S (2010). Subjective Effects of Methylphenidate, 275-304. [doi]  [abs]
  96. Markunas, CA; Quinn, KS; Collins, AL; Garrett, ME; Lachiewicz, AM; Sommer, JL; Morrissey-Kane, E; Kollins, SH; Anastopoulos, AD; Ashley-Koch, AE (2010). Genetic variants in SLC9A9 are associated with measures of attention-deficit/hyperactivity disorder symptoms in families.. Psychiatr Genet, 20(2), 73-81. [20032819], [doi]  [abs]
  97. Polanczyk, G; Caspi, A; Houts, R; Kollins, SH; Rohde, LA; Moffitt, TE (2010). Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort.. J Am Acad Child Adolesc Psychiatry, 49(3), 210-216. [20410710], [doi]  [abs]
  98. Faraone, SV; Spencer, TJ; Kollins, SH; Glatt, SJ (2010). Effects of lisdexamfetamine dimesylate treatment for ADHD on growth.. J Am Acad Child Adolesc Psychiatry, 49(1), 24-32. [20215923], [doi]  [abs]
  99. Volkow, ND; Wang, G-J; Kollins, SH; Wigal, TL; Newcorn, JH; Telang, F; Fowler, JS; Zhu, W; Logan, J; Ma, Y; Pradhan, K; Wong, C; Swanson, JM (2009). Evaluating dopamine reward pathway in ADHD: clinical implications.. Jama, 302(10), 1084-1091. [19738093], [doi]  [abs]
  100. Wigal, SB; Kollins, SH; Childress, AC; Squires, L; 311 Study Group, (2009). A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.. Child and Adolescent Psychiatry and Mental Health, 3(1), 17. [19508731], [doi]  [abs]
  101. Kollins, SH; Garrett, ME; McClernon, FJ; Lachiewicz, AM; Morrissey-Kane, E; FitzGerald, D; Collins, AL; Anastopoulos, AD; Ashley-Koch, AE (2009). Effects of postnatal parental smoking on parent and teacher ratings of ADHD and oppositional symptoms.. J Nerv Ment Dis, 197(6), 442-449. [19525745], [doi]  [abs]
  102. Fuemmeler, BF; Agurs-Collins, T; McClernon, FJ; Kollins, SH; Garrett, ME; Ashley-Koch, AE (2009). Interactions between genotype and depressive symptoms on obesity.. Behav Genet, 39(3), 296-305. [19337825], [doi]  [abs]
  103. Kollins, SH; English, J; Robinson, R; Hallyburton, M; Chrisman, AK (2009). Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD).. Psychopharmacology (Berl), 204(1), 73-83. [19104775], [doi]  [abs]
  104. Willoughby, MT; Kollins, SH; McClernon, FJ; Family Life Investigative Group, (2009). Association between smoking and retrospectively reported attention-deficit/hyperactivity disorder symptoms in a large sample of new mothers.. Nicotine Tob Res, 11(3), 313-322. [19307443], [doi]  [abs]
  105. Kollins, SH; McClernon, FJ; Epstein, JN (2009). Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis.. Drug Alcohol Depend, 100(1-2), 169-172. [19041198], [doi]  [abs]
  106. Kollins, SH; Anastopoulos, AD; Lachiewicz, AM; FitzGerald, D; Morrissey-Kane, E; Garrett, ME; Keatts, SL; Ashley-Koch, AE (2008). SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families.. Am J Med Genet B Neuropsychiatr Genet, 147B(8), 1580-1588. [18821566], [doi]  [abs]
  107. Witt, KL; Shelby, MD; Itchon-Ramos, N; Faircloth, M; Kissling, GE; Chrisman, AK; Ravi, H; Murli, H; Mattison, DR; Kollins, SH (2008). Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD.. J Am Acad Child Adolesc Psychiatry, 47(12), 1375-1383. [18978633], [doi]  [abs]
  108. McClernon, FJ; Kollins, SH (2008). ADHD and smoking: from genes to brain to behavior.. Ann N Y Acad Sci, 1141, 131-147. [18991955], [doi]  [abs]
  109. Kollins, SH (2008). ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.. Journal of Attention Disorders, 12(2), 115-125. [18192623], [doi]  [abs]
  110. Adler, LA; Goodman, DW; Kollins, SH; Weisler, RH; Krishnan, S; Zhang, Y; Biederman, J; 303 Study Group, (2008). Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.. The Journal of Clinical Psychiatry, 69(9), 1364-1373. [19012818]  [abs]
  111. Kollins, SH (2008). A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.. Curr Med Res Opin, 24(5), 1345-1357. [18384709], [doi]  [abs]
  112. McClernon, FJ; Kollins, SH; Lutz, AM; Fitzgerald, DP; Murray, DW; Redman, C; Rose, JE (2008). Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study.. Psychopharmacology, 197(1), 95-105. [18038223], [doi]  [abs]
  113. Fuemmeler, BF; Agurs-Collins, TD; McClernon, FJ; Kollins, SH; Kail, ME; Bergen, AW; Ashley-Koch, AE (2008). Genes implicated in serotonergic and dopaminergic functioning predict BMI categories.. Obesity (Silver Spring, Md.), 16(2), 348-355. [18239643], [doi]  [abs]
  114. McClernon, FJ; Fuemmeler, BF; Kollins, SH; Kail, ME; Ashley-Koch, AE (2008). Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults.. Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco, 10(1), 117-127. [18188752], [doi]  [abs]
  115. Laforett, DR; Murray, DW; Kollins, SH (2008). Psychosocial treatments for preschool-aged children with Attention-Deficit Hyperactivity Disorder.. Dev Disabil Res Rev, 14(4), 300-310. [19072758], [doi]  [abs]
  116. Kollins, SH; March, JS (2007). Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.. Biological Psychiatry, 62(9), 951-953. [17950067], [doi]
  117. Fuemmeler, BF; Kollins, SH; McClernon, FJ (2007). Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood.. Journal of Pediatric Psychology, 32(10), 1203-1213. [17602186], [doi]  [abs]
  118. Posner, K; Melvin, GA; Murray, DW; Gugga, SS; Fisher, P; Skrobala, A; Cunningham, C; Vitiello, B; Abikoff, HB; Ghuman, JK; Kollins, S; Wigal, SB; Wigal, T; McCracken, JT; McGough, JJ; Kastelic, E; Boorady, R; Davies, M; Chuang, SZ; Swanson, JM; Riddle, MA; Greenhill, LL (2007). Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 547-562. [doi]  [abs]
  119. Ghuman, JK; Riddle, MA; Vitiello, B; Greenhill, LL; Chuang, SZ; Wigal, SB; Kollins, SH; Abikoff, HB; McCracken, JT; Kastelic, E; Scharko, AM; McGough, JJ; Murray, DW; Evans, L; Swanson, JM; Wigal, T; Posner, K; Cunningham, C; Davies, M; Skrobala, AM (2007). Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 563-580. [17979578], [doi]  [abs]
  120. Pettiford, J; Kozink, RV; Lutz, AM; Kollins, SH; Rose, JE; McClernon, FJ (2007). Increases in impulsivity following smoking abstinence are related to baseline nicotine intake and boredom susceptibility.. Addictive Behaviors, 32(10), 2351-2357. [17399907], [doi]  [abs]
  121. Swanson, JM; Moyzis, RK; McGough, JJ; McCracken, JT; Riddle, MA; Kollins, SH; Greenhill, LL; Abikoff, HB; Wigal, T; Wigal, SB; Posner, K; Skrobala, AM; Davies, M; Ghuman, JK; Cunningham, C; Vitiello, B; Stehli, A; Smalley, SL; Grady, D (2007). Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 635-646. [17979583], [doi]  [abs]
  122. Hardy, KK; Kollins, SH; Murray, DW; Riddle, MA; Greenhill, L; Cunningham, C; Abikoff, HB; McCracken, JT; Vitiello, B; Davies, M; McGough, JJ; Posner, K; Skrobala, AM; Swanson, JM; Wigal, T; Wigal, SB; Ghuman, JK; Chuang, SZ (2007). Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 621-634. [17979582], [doi]  [abs]
  123. Murray, DW; Kollins, SH; Hardy, KK; Abikoff, HB; Swanson, JM; Cunningham, C; Vitiello, B; Riddle, MA; Davies, M; Greenhill, LL; McCracken, JT; McGough, JJ; Posner, K; Skrobala, AM; Wigal, T; Wigal, SB; Ghuman, JK; Chuang, SZ (2007). Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 605-620. [17979581], [doi]  [abs]
  124. Vitiello, B; Abikoff, HB; Chuang, SZ; Kollins, SH; McCracken, JT; Riddle, MA; Swanson, JM; Wigal, T; McGough, JJ; Ghuman, JK; Wigal, SB; Skrobala, AM; Davies, M; Posner, K; Cunningham, C; Greenhill, LL (2007). Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 593-604. [17979580], [doi]  [abs]
  125. Abikoff, HB; Vitiello, B; Riddle, MA; Cunningham, C; Greenhill, LL; Swanson, JM; Chuang, SZ; Davies, M; Kastelic, E; Wigal, SB; Evans, L; Ghuman, JK; Kollins, SH; McCracken, JT; McGough, JJ; Murray, DW; Posner, K; Skrobala, AM; Wigal, T (2007). Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 581-592. [17979579], [doi]  [abs]
  126. Kratochvil, CJ; Vaughan, BS; Mayfield-Jorgensen, ML; March, JS; Kollins, SH; Murray, DW; Ravi, H; Greenhill, LL; Kotler, LA; Paykina, N; Biggins, P; Stoner, J (2007). A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.. Journal of Child and Adolescent Psychopharmacology, 17(2), 175-185. [17489712], [doi]  [abs]
  127. Levin, FR (2007). ADHD and Sustance Abuse Update. American Journal on Addictions, 16(s1), 1-4. [Gateway.cgi], [doi]
  128. Kollins, SH (2007). Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).. American Journal on Addictions, 16 Suppl 1, 35-42. [17453605], [doi]  [abs]
  129. McGough, J; McCracken, J; Swanson, J; Riddle, M; Kollins, S; Greenhill, L; Abikoff, H; Davies, M; Chuang, S; Wigal, T; Wigal, S; Posner, K; Skrobala, A; Kastelic, E; Ghuman, J; Cunningham, C; Shigawa, S; Moyzis, R; Vitiello, B (2006). Pharmacogenetics of methylphenidate response in preschoolers with ADHD.. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1314-1322. [doi]  [abs]
  130. Kollins, S; Greenhill, L; Swanson, J; Wigal, S; Abikoff, H; McCracken, J; Riddle, M; McGough, J; Vitiello, B; Wigal, T; Skrobala, A; Posner, K; Ghuman, J; Davies, M; Cunningham, C; Bauzo, A (2006). Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1275-1283. [doi]  [abs]
  131. Wigal, T; Greenhill, L; Chuang, S; McGough, J; Vitiello, B; Skrobala, A; Swanson, J; Wigal, S; Abikoff, H; Kollins, S; McCracken, J; Riddle, M; Posner, K; Ghuman, J; Davies, M; Thorp, B; Stehli, A (2006). Safety and tolerability of methylphenidate in preschool children with ADHD.. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1294-1303. [doi]  [abs]
  132. Greenhill, L; Kollins, S; Abikoff, H; McCracken, J; Riddle, M; Swanson, J; McGough, J; Wigal, S; Wigal, T; Vitiello, B; Skrobala, A; Posner, K; Ghuman, J; Cunningham, C; Davies, M; Chuang, S; Cooper, T (2006). Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1284-1293. [doi]  [abs]
  133. Swanson, J; Greenhill, L; Wigal, T; Kollins, S; Stehli, A; Davies, M; Chuang, S; Vitiello, B; Skrobala, A; Posner, K; Abikoff, H; Oatis, M; McCracken, J; McGough, J; Riddle, M; Ghuman, J; Cunningham, C; Wigal, S (2006). Stimulant-related reductions of growth rates in the PATS.. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1304-1313. [doi]  [abs]
  134. Epstein, JN; Kollins, SH (2006). Psychometric properties of an adult ADHD diagnostic interview.. Journal of Attention Disorders, 9(3), 504-514. [16481667], [doi]  [abs]
  135. Kollins, SH; Greenhill, L (2006). Evidence base for the use of stimulant medication in preschool children with ADHD. Infants & Young Children, 19(2), 132-141. [doi]  [abs]
  136. Preston, RJ; Kollins, SH; Swanson, JM; Greenhill, LL; Wigal, T; Elliott, GR; Vitiello, B (2005). Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.. Cancer Letters, 230(2), 292-294. [16019134], [doi]
  137. MacDonald Fredericks, E; Kollins, SH (2005). A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder.. Journal of Child and Adolescent Psychopharmacology, 15(5), 729-741. [16262590], [doi]  [abs]
  138. Kollins, SH; McClernon, FJ; Fuemmeler, BF (2005). Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults.. Archives of General Psychiatry, 62(10), 1142-1147. [16203959], [doi]  [abs]
  139. Wigal, SB; McGough, JJ; McCracken, JT; Biederman, J; Spencer, TJ; Posner, KL; Wigal, TL; Kollins, SH; Clark, TM; Mays, DA; Zhang, Y; Tulloch, SJ (2005). A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.. Journal of Attention Disorders, 9(1), 275-289. [16371674], [doi]  [abs]
  140. Fredericks, EM; Kollins, SH (2004). Assessing methylphenidate preference in ADHD patients using a choice procedure.. Psychopharmacology, 175(4), 391-398. [15258716], [doi]  [abs]
  141. Swanson, JM; Wigal, SB; Wigal, T; Sonuga-Barke, E; Greenhill, LL; Biederman, J; Kollins, S; Nguyen, AS; DeCory, HH; Hirshe Dirksen, SJ; Hatch, SJ; COMACS Study Group, (2004). A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).. Pediatrics, 113(3 Pt 1), e206-e216. [doi]  [abs]
  142. Kollins, SH (2003). Delay discounting is associated with substance use in college students.. Addictive Behaviors, 28(6), 1167-1173. [12834659], [doi]  [abs]
  143. Kollins, SH (2003). Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.. The Journal of Clinical Psychiatry, 64 Suppl 11, 14-18. [14529325]  [abs]
  144. Kollins, SH; Rush, CR (2002). Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans.. Biological Psychiatry, 51(2), 143-150. [11822993], [doi]  [abs]
  145. Kollins, SH; MacDonald, EK; Rush, CR (2001). Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review.. Pharmacology, Biochemistry, and Behavior, 68(3), 611-627. [11325419], [doi]  [abs]
  146. Kollins, SH; Barkley, RA; DuPaul, GJ (2001). Use and management of medications for children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Focus on Exceptional Children, 33(5), X-24.
  147. Kollins, SH; Barkley, RA; DuPaul, GJ (2001). Use and management of medications for children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Focus on Exceptional Children, 33(5), X-24.
  148. Kollins, SH; Barkley, RA; DuPaul, GJ (2001). Use and management of medications for children diagnosed with attention deficit hyperactivity disorder (ADHD). Focus on Exceptional Children, 33(5), 1-+.
  149. Critchfield, TS; Kollins, SH (2001). Temporal discounting: basic research and the analysis of socially important behavior.. Journal of Applied Behavior Analysis, 34(1), 101-122. [11317983], [doi]  [abs]
  150. Critchfield, TS; Newland, MC; Kollins, SH (2000). The good, the bad, and the aggregate.. The Behavior Analyst, 23(1), 107-115. [22478342], [doi]  [abs]
  151. Murray, LK; Kollins, SH (2000). Effects of methylphenidate on sensitivity to reinforcement in children diagnosed with attention deficit hyperactivity disorder: an application of the matching law.. Journal of Applied Behavior Analysis, 33(4), 573-591. [11214032], [doi]  [abs]
  152. Kollins, SH; Rush, CR (1999). Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.. Pharmacology, Biochemistry, and Behavior, 64(2), 319-326. [10515308], [doi]  [abs]
  153. Forsyth, JP; Kollins, S; Palav, A; Duff, K; Maher, S (1999). Has behavior therapy drifted from its experimental roots? A survey of publication trends in mainstream behavioral journals.. Journal of Behavior Therapy and Experimental Psychiatry, 30(3), 205-220. [doi]  [abs]
  154. Daleiden, EL; Chorpita, BF; Kollins, SH; Drabman, RS (1999). Factors affecting the reliability of clinical judgments about the function of children's school-refusal behavior.. Journal of Clinical Child Psychology, 28(3), 396-406. [10446689], [doi]  [abs]
  155. Phillips, EL; Kollins, S; Edgerly, D (1999). Behavioural assessment of children and adolescents.. The Indian Journal of Pediatrics, 66(3), 389-399. [doi]  [abs]
  156. Kollins, SH; Newland, MC; Critchfield, TS (1999). Quantitative integration of single-subject studies: Methods and misinterpretations.. The Behavior Analyst, 22(2), 149-157. [22478332], [doi]  [abs]
  157. Kollins, SH; Rush, CR; Pazzaglia, PJ; Ali, JA (1998). Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.. Experimental and Clinical Psychopharmacology, 6(4), 367-374. [9861551], [doi]  [abs]
  158. Kollins, SH; Shapiro, SK; Newland, MC; Abramowitz, A (1998). Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).. Experimental and Clinical Psychopharmacology, 6(4), 375-389. [9861552], [doi]  [abs]
  159. Rush, CR; Kollins, SH; Pazzaglia, PJ (1998). Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.. Experimental and Clinical Psychopharmacology, 6(1), 32-44. [9526144], [doi]  [abs]
  160. Kollins, SH; Newland, MC; Critchfield, TS (1997). Erratum to: Human sensitivity to reinforcement in operant choice: How much do consequences matter?. Psychonomic Bulletin & Review, 4(3), 431-431. [Gateway.cgi], [doi]
  161. Kollins, SH; Newland, MC; Critchfield, TS (1997). Human sensitivity to reinforcement in operant choice: How much do consequences matter?. Psychonomic Bulletin & Review, 4(2), 208-220. [21331827], [doi]  [abs]
  162. Kollins, SH; Lane, SD; Shapiro, SK (1997). Experimental analysis of childhood psychopathology: A laboratory matching analysis of the behavior of children diagnosed with Attention-Deficit Hyperactivity Disorder (ADHD). The Psychological Record, 47(1), 25-44. [doi]  [abs]

Chapters in Books

  1. Lunsford-Avery, JR; Kollins, SH; Krystal, AD "SLEEPING AT HOME: FEASIBILITY AND TOLERABILITY OF AMBULATORY POLYSOMNOGRAPHY FOR USE WITH ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER."  OXFORD UNIV PRESS INC, April, 2018: A283-A284.
  2. Murphy, SK; Schrott, R; Visco, Z; Huang, Z; Grenier, C; Mitchell, J; Schechter, J; Lucas, J; Levin, ED; Price, T; Kollins, SH "Environment and Gametic Epigenetic Reprogramming.."  WILEY, September, 2017: S28-S28.
  3. Kollins, SH; McClernon, FJ "ADHD and smoking." Attention-Deficit Hyperactivity Disorder in Adults and Children. Cambridge University Press, January, 2015: 327-342. [doi]  [abs]
  4. McClernon, FJ; Mitchell, JT; Schick, RS; Bayham, RL; Dennis, ME; Kollins, SH; Beckham, JC "COMBINED EMA AND GPS FOR ASSESSING THE SPATIAL DISTRIBUTION OF SMOKING BEHAVIOR: A PROOF OF CONCEPT STUDY."  SPRINGER, March, 2013: S93-S93.
  5. Mitchell, JT; Kollins, SH "Attention-deficit/hyperactivity disorder in adolescence." Handbook of Adolescent Health Psychology. Springer New York, January, 2013: 423-445. [doi]
  6. Mitchell, JT; Kollins, SH "ADHD in adolescence." Adolescent health psychology. Ed. O'Donohue, W; Benuto, L; Tolle, L SPRINGER, 2013: 423-445.
  7. Bidwell, LC; Garrett, ME; McClernon, FJ; Fuemmeler, BF; Williams, RB; Ashley-Koch, AE; Kollins, SH "Genotype and ADHD symptoms interact to predict adolescents' early smoking experiences in an epidemiological sample."  SPRINGER, November, 2011: 893-893. [Gateway.cgi]
  8. Kollins, SH "Abuse potential of stimulant drugs used to treat ADHD." ADHD in Adults: Characterization, Diagnosis, and Treatment. Cambridge University Press, January, 2011: 230-239. [doi]  [abs]
  9. Witt, KL; Shelby, MD; Itchon-Ramos, N; Faircloth, M; Kissling, GE; Chrisman, AK; Ravi, H; Murli, H; Mattison, DR; Kollins, SH "Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of pediatric ADHD patients treated with stimulant drugs."  WILEY-BLACKWELL, August, 2008: 528-528. [Gateway.cgi]
  10. Goodman, D; Adler, L; Kollins, SH; Weisler, R; Krishnan, S; Zhang, Y; Biederman, J "Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder."  CAMBRIDGE UNIV PRESS, July, 2008: 292-293. [Gateway.cgi]
  11. Kollins, SH; Wigal, T; Vince, B; Lyne, A; Farrand, K "Cognitive and sedative effects of guanfacine extended release in children and adolescents aged 6 to 17 years with attention-deficit/hyperactivity disorder: Safety and sleep effects."  ELSEVIER SCIENCE INC, April, 2008: 246S-246S. [Gateway.cgi]
  12. Kollins, S; Epstein, J; Tonev, S; Anastopoulos, A; Lachiewicz, A; Fitzgerald, D; Kane, E; Kail, M; Cuccaro, M; Exelbierd, L; Gilbert, J; Ashley-Koch, A "Genetic associations with reaction time variability in AD/HD."  WILEY-LISS, October, 2006: 771-772.
  13. Schug, MD; Anastopoulos, A; Kollins, S; Hennis, L; Nelson, S; Mehltretter, L; Gilbert, J; Cuccaro, M; Ashley-Koch, A "The genetics of AD/HD: Subtyping, comorbidity and developmental considerations."  WILEY-LISS, September, 2004: 103-103.

Duke University * Arts & Sciences * Faculty * Staff * Grad * Postdocs * Reload * Login